Evidence map›Paper›PMID 30992678›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2019

Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions.

Helena Kratochvilova, Zdenka Lacinova, Jana Klouckova, Petra Kavalkova, Anna Cinkajzlova, Pavel Trachta, Jarmila Krizova, Marek Benes, Karin Dolezalova, Martin Fried and 5 more

Open access · goldAbstract read
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Serum Neudesin Levels in Patients with Congenital HypothyroidismJournal of clinical research in pediatric endocrinology · 2025
    Article
  2. Article
  3. Article
  4. Serum Neudesin Levels in Obese AdolescentsJournal of clinical research in pediatric endocrinology · 2022
    Article
  5. Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open.International journal of environmental research and public health · 2022
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Helena KratochvilovaCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, martin.haluzik@ikem.cz.
Zdenka LacinovaCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, martin.haluzik@ikem.cz.
Jana KlouckovaCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, martin.haluzik@ikem.cz.
Petra KavalkovaDepartment of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University, Prague, Czech Republic, martin.haluzik@ikem.cz.
Anna CinkajzlovaCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, martin.haluzik@ikem.cz.
Pavel TrachtaThird Department of Medicine, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Jarmila KrizovaThird Department of Medicine, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Marek BenesHepatogastroenterology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Karin DolezalovaDepartment of Surgery, OB Clinic, Prague, Czech Republic.
Martin FriedDepartment of Surgery, OB Clinic, Prague, Czech Republic.
Zuzana VlasakovaDiabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, martin.haluzik@ikem.cz.
Terezie PelikanovaDiabetes Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, martin.haluzik@ikem.cz.
Julius SpicakHepatogastroenterology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Milos MrazDepartment of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University, Prague, Czech Republic, martin.haluzik@ikem.cz.
Martin HaluzikCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, martin.haluzik@ikem.cz.
Charles University · CZInstitute of Clinical and Experimental Medicine · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextNeudesin has recently been identified as a novel regulator of energy expenditure in experimental animals; however, its role in humans remains unexplored.

objectiveThe aim of this study was to assess the effects of obesity and type 2 diabetes mellitus (T2DM) along with selected weight reducing interventions on serum neudesin levels and adipose tissue mRNA expression. PATIENTS AND

methodsFifteen obese subjects with T2DM undergoing endoscopic duodenal-jejunal bypass liner (DJBL) implantation, 17 obese subjects (11 with T2DM, 6 without T2DM) scheduled for gastric plication (GP), 15 subjects with functional hypoglycemia subjected to 72-hour acute fasting (AF), and 12 healthy controls were included in the study.

resultsBaseline neudesin levels were comparable between all groups. DJBL increased neudesin at 6 and 10 months after the procedure (1.77±0.86 vs 2.28±1.27 vs 2.13±1.02 ng/mL,

conclusionNeudesin levels are differentially regulated during AF and chronic weight reduction induced by DJBL or GP. Further studies are needed to assess its possible significance in energy homeostasis regulation in humans.

Indexed as

acute fastingbariatric surgeryenergy homeostasisneudesinobesitytype 2 diabetes mellitusweight reduction

Identifiers

PMID30992678
PMCPMC6445223
OpenAlexW2924328672

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.